Parmar Kush

Director, 10% OwnerEntrada Therapeutics, Inc. (TRDA) · full profile →Form 4 · filed Aug 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$807K
Net Open-Market Flow
-$807K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 31, 2026Sell(S)2K$6.85$12K2.8M
Jul 30, 2026Sell(S)115K$6.93$795K2.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001664281-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.